Sayana Press (DMPA-SC in Uniject) Clinical Brief

This brief provides a clinical overview of the injectable contraceptive Sayana® Press, which contains 30% less depot medroxyprogesterone acetate than the intramuscular presentation of Depo-Provera®. It is administered subcutaneously through the prefilled Uniject injection system, an autodisable injection device. For more information, please visit our Reproductive Health Global Program website.

Publication date: March 2017

Available materials

  1. English

    1. Sayana Press (DMPA-SC in Uniject) Clinical Brief 630.3 KB PDF

      Hard copies are available.

  2. French

    1. Sayana Press (DMPA-SC in Uniject) Clinical Brief [French] 636.1 KB PDF

      Hard copies are available.